Correction: A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer.

Schweizer, Michael T; Haugk, Kathleen; McKiernan, Jožefa S; Gulati, Roman; Cheng, Heather H; Maes, Jessica L; Dumpit, Ruth F; Nelson, Peter S et al. · PLoS One · 2018

Where this comes from

Record sourced from PubMed, PMID 30110398.
Also identified by DOI 10.1371/journal.pone.0202709 and PMC identifier 6093693.
No licence information is recorded for this record.
Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0198389.].

Read the full text

View on PubMed · Publisher (DOI)